Study of the Efficacy and Safety of Lonidamine for the Treatment of Symptomatic Benign Prostatic Hyperplasia

NCT00435448 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia
Enlarged Prostate

Interventions

DRUG: Lonidamine

Sponsor

Threshold Pharmaceuticals

Collaborators

[object Object]